SCHEMBL19081305

SCHEMBL19081305

CC1(C)c2ccc3c(sc4cc(-c5ccc(-c6c7ccccc7c(-c7cccc8ccccc78)c7ccccc67)c6ccccc56)ccc43)c2-c2ccc3ccccc3c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.36
LIMK1 P53667 2/20 0.33
MCL1 Q07820 2/20 0.32
ACMSD Q8TDX5 1/20 0.32
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA9 Q16790 2/20 0.31
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
CHRNA1 P02708 1/20 0.30
CHRNG P07510 1/20 0.30
CHRNB1 P11230 1/20 0.30
CHRNB2 P17787 1/20 0.30
SLC6A2 P23975 1/20 0.30
CHRNB4 P30926 1/20 0.30
SLC6A4 P31645 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA4 P43681 1/20 0.30
SLC6A3 Q01959 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081078 0.96 ALOX5 (0.34) ALOX5LIMK1CA12CA1CA2
SCHEMBL19081307 0.93 ALOX5 (0.36) ALOX5LIMK1MCL1ACMSDCA12
SCHEMBL19081061 0.88 ALOX5 (0.33) ALOX5CA12CA1CA2CA9
SCHEMBL19081110 0.87 CYP1A1 (0.34) ALOX5LIMK1MCL1CYP1A1CYP1B1
SCHEMBL19081144 0.85 F9 (0.33) ALOX5LIMK1MCL1CYP1A1CYP1B1
SCHEMBL19077098 0.85 ALOX5 (0.31) ALOX5
SCHEMBL19109633 0.84 ALOX5 (0.40) ALOX5MCL1ACMSDCA12CA1
SCHEMBL17932241 0.84 ALOX5 (0.33) ALOX5LIMK1CA12CA1CA2
SCHEMBL17944391 0.84 ALOX5 (0.44) ALOX5LIMK1MCL1ACMSDCA12
SCHEMBL19081299 0.83 CHRNA1 (0.31) ALOX5MCL1ACMSDCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885LIMK1 440/4885MCL1 1139/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885LIMK1 440/4885MCL1 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.